...
首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >Evaluation of multiplex PCR in first episodes of febrile neutropenia as a tool to improve early yeast diagnosis in leukemic/preleukemic patients.
【24h】

Evaluation of multiplex PCR in first episodes of febrile neutropenia as a tool to improve early yeast diagnosis in leukemic/preleukemic patients.

机译:在发热性中性粒细胞减少症的首发中评估多重PCR作为改善白血病/白血病前期患者早期酵母诊断的工具。

获取原文
获取原文并翻译 | 示例
           

摘要

In febrile neutropenic onco-hematological patients, delayed microbiological diagnosis leads to an increase in morbidity and mortality. Identification of the microorganism changes antibiotic therapy in more than half of cases; however, in only 20-30 % of such cases pathogen isolation is achieved. This study evaluates the frequency of fungus infection and its etiology in onco-hematological patients with febrile neutropenia utilizing blood cultures and non-commercial multiplex polymerase chain reaction (MT-PCR) primers. Fifty-three febrile neutropenia episodes in 35 onco-hematological patients were observed, and the results for the first unique 30 episodes are presented. Blood cultures were positive for Candida tropicalis (one case), gram-positive bacteria (two cases), and gram-negative bacteria (four cases), showing a 23.3 % microbiological isolation rate. Multiplex-PCR pan-fungal sequence was positive in 18 cases (60 %), and further sequencing identified fugal pathogens in 11 cases (Candida glabrata and Candida parapsilosis being the most common). MT-PCR pan-fungal sequence amplification was detected in 13 of 16 patients that later received antifungal treatment for clinical reasons only, while positivity was found in 5 out of 14 patients that did not receive antifungal treatment (p?=?0.02). These results show that performing in-house non-commercial MT-PCR is feasible and may provide additional information about fungal infection without the need to wait for culture results. Further research is necessary to incorporate this technology into the decision-making process.
机译:在发热性中性粒细胞减少的肿瘤血液学患者中,延迟的微生物学诊断导致发病率和死亡率增加。在一半以上的病例中,微生物的鉴定改变了抗生素治疗;但是,在这种情况下,只有20%至30%的病原菌得以分离。本研究通过血液培养和非商业性多重聚合酶链反应(MT-PCR)引物评估发热性中性粒细胞减少的肿瘤血液学患者的真菌感染频率及其病因。观察了35例血液肿瘤患者的53例发热性中性粒细胞减少症发作,并给出了最初30例中唯一的发作结果。血培养对热带念珠菌(1例),革兰氏阳性菌(2例)和革兰氏阴性菌(4例)呈阳性,显示微生物分离率为23.3%。多重PCR泛真菌序列阳性18例(占60%),进一步测序鉴定出11例真菌病原体(最常见的是光滑念珠菌和副念珠菌)。后来仅出于临床原因接受抗真菌治疗的16例患者中有13例检测到MT-PCR泛真菌序列扩增,而未接受抗真菌治疗的14例患者中有5例检测到阳性(p?=?0.02)。这些结果表明,进行内部非商业性MT-PCR是可行的,并且可以提供有关真菌感染的其他信息,而无需等待培养结果。有必要进行进一步的研究以将该技术纳入决策过程。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号